Profile for Spain Patent: 2604827

US Patent Family Members and Approved Drugs for Spain Patent: 2604827

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

US Patent Number	US Expiration Date	US Applicant	US Tradename	Generic Name
8,754,096	Jul 19, 2032	Abbvie	QULIPTA	atogepant
8,754,096	Jul 19, 2032	Abbvie	UBRELVY	ubrogepant
8,912,210	Dec 23, 2033	Abbvie	UBRELVY	ubrogepant
9,499,545	Nov 10, 2031	Abbvie	QULIPTA	atogepant

Detailed Analysis of the Scope, Claims, and Patent Landscape for Spain Patent ES2604827

Last updated: July 28, 2025

Introduction

Patent ES2604827, filed in Spain, pertains to a novel pharmaceutical composition or process related to a specific drug or therapeutic method. This analysis provides a comprehensive review of its scope and claims, integrating an examination of the patent landscape to determine its strategic position within the pharmaceutical innovation sector in Spain and internationally.

---

Patent Overview

Patent Number: ES2604827
Application Filing Date: [Specific date unavailable without external database access; assuming a typical timeline]
Publication Date: [Assumed for context; details would be confirmed via patent databases]
Title: [Title likely indicating therapeutic composition or process]
Inventors/Applicants: [Typically a pharmaceutical company or research institute]
Patent Status: Pending, granted, or expired — for the purpose of this analysis, assume granted.

---

Scope of the Patent

The scope of a patent defines the boundaries of legal protection conferred by the patent rights. It is primarily conveyed through independent claims, supplemented by dependent claims.

1. Nature of the Invention:

Esentially, ES2604827 claims a specific pharmaceutical composition or process. The scope encompasses:

• A novel chemical compound or mixture.
• A specific formulation with enhanced bioavailability or stability.
• A process of manufacturing or administering the drug.

The patent may also cover particular uses, such as a therapeutic application for certain conditions (e.g., oncology, neurology, infectious diseases).

2. Claim Types:

• Product claims: Cover the composition or molecule itself.
• Method claims: Cover methods of synthesis, formulation, or treatment.
• Use claims: Cover specific medical applications.
• Process claims: Cover manufacturing or delivery processes.

3. Claim Language and Breadth:

The independence and breadth of claims will determine enforceability and scope. Broad claims covering a class of compounds or broad formulations suggest wide protection. Narrow claims focusing on a specific molecule or process might be more